| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $106.7M | +30.0% |
| SG&A Expense | $44.8M | -36.8% |
| Operating Income | -$151.5M | +1.0% |
| Interest Expense | $12K | -94.4% |
| Pre-tax Income | -$129.5M | +12.1% |
| Income Tax | $6.0M | +569.2% |
| Net Income | -$35.5M | +76.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.6M | -87.6% |
| Current Assets | $374.1M | -25.9% |
| Total Assets | $420.6M | -18.8% |
| Current Liabilities | $25.0M | +130.3% |
| Total Liabilities | $29.2M | +123.8% |
| Stockholders' Equity | -$1.10B | -0.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$90.1M | -16.8% |
| Capital Expenditures | $34.2M | +1752.5% |
| Investing Cash Flow | -$330.0M | — |
| Financing Cash Flow | -$9.6M | -101.7% |
| Free Cash Flow | -$124.3M | -57.4% |